DrugPatentWatch Database Preview
Investigational Drug Information for D-Tryptophan
Email this page to a colleague
What is the development status for investigational drug D-Tryptophan?
D-Tryptophan is an investigational drug.
There have been 18 clinical trials for D-Tryptophan.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 9th 2020.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Adenocarcinoma, and Breast Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), NewLink Genetics Corporation, and Southwest Oncology Group.
There is one US patent protecting this investigational drug and eight international patents.
Summary for D-Tryptophan
| US Patents | 1,157 |
| International Patents | 8,732 |
| US Patent Applications | 1,985 |
| WIPO Patent Applications | 1,428 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2020-12-09) |
| Vendors | 94 |
Recent Clinical Trials for D-Tryptophan
| Title | Sponsor | Phase |
|---|---|---|
| Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score | National Cancer Institute (NCI) | Phase 3 |
| Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score | NRG Oncology | Phase 3 |
| Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery | Advanced Accelerator Applications | Phase 1 |
Clinical Trial Summary for D-Tryptophan
Top disease conditions for D-Tryptophan
Top clinical trial sponsors for D-Tryptophan
US Patents for D-Tryptophan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| D-Tryptophan | ⤷ Sign up for a Free Trial | Generation of cytotoxic tumor specific cell lines and uses thereof | Ramot at Tel-Aviv University Ltd. (Tel-Aviv, IL) | ⤷ Sign up for a Free Trial |
| D-Tryptophan | ⤷ Sign up for a Free Trial | Nuclear targeting sequences | Yeda Research and Development Co. Ltd. (Rehovot, IL) | ⤷ Sign up for a Free Trial |
| D-Tryptophan | ⤷ Sign up for a Free Trial | Use of GPR83 to identify pruritus-related substances | University of Miyazaki (Miyazaki, JP) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-Tryptophan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| D-Tryptophan | European Patent Office | EP2950808 | 2033-02-04 | ⤷ Sign up for a Free Trial |
| D-Tryptophan | World Intellectual Property Organization (WIPO) | WO2014118785 | 2033-02-04 | ⤷ Sign up for a Free Trial |
| D-Tryptophan | European Patent Office | EP2134373 | 2027-02-28 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
